A Study on the Efficacy and Safety of Bevacizumab in Untreated Patients With Locally Advanced Cervical Cancer
Status:
Recruiting
Trial end date:
2022-05-31
Target enrollment:
Participant gender:
Summary
To verify the clinical efficacy and safety of bevacizumab in treating local advanced cervical
cancer, present study was designed to investigate the clinical results of bevacizumab
combined with concurrent chemoradiotherapy (CCRT) in local advanced cervical cancer
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Air Force Military Medical University, China Fourth Military Medical University